Multivitamins are the most common dietary supplement in the U.S. People take these pills (or gummies, indeed) for a variety of health reasons, but the science on what multivitamins may do for your ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) ...

Scientists at Brigham and Women’s Hospital and others studied thousands of older adults who were asked to take a daily multivitamin and multimineral supplement. They found evidence that daily ...

X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg dose compared with -10.4% for placebo (p=0.000000000006 ...

Black sesame is the latest plant-based product to go viral, with its appealing colour and nutty taste. Do the facts match the hype?

This article was reviewed by Knox Beasley. Key Takeaways: 1mg oral finasteride effectively treats hair loss and is the ...

Pfizer ( PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed ...

AbbVie Inc. (NYSE: ABBV ) is one of the best undervalued stocks to invest in right now.

A pilot clinical trial has found that low-dose lithium tablets might help slow verbal decline among seniors with mild ...

Taking a multivitamin every day might slightly slow the rate of ageing, but the extent to which this is relevant to our health is unclear ...

Relacorilant, a selective glucocorticoid receptor modulator, provides sustained blood pressure control and metabolic benefits in patients with Cushing syndrome, according to a phase 3 trial.

People 18 years or older with ASD and who have a significant mood disorder or other behaviors that interfere with function and quality of life are needed to take part in a Johns Hopkins research study ...